Denmark-based medical device company Novo Nordisk has obtained the US Food and Drug Administration (FDA) approval for its NovoLog (insulin aspart [rDNA origin] injection) FlexTouch and Levemir (insulin detemir [rDNA origin] injection) ...
Global healthcare company Novo Nordisk has obtained an approval from Health Canada for the Levemir FlexTouch, a new disposable insulin injection pen device for use in insulin-treated patients with type 1 and type 2 diabetes mellitus. Novo ...
Tags: Novo Nordisk, Insulin Pen
Novo Nordisk has received approval from Health Canada for its Levemir FlexTouch, a disposable prefilled insulin pen containing Levemir (insulin detemir), designed to treat patients with type 1 and type 2 diabetes. FlexTouch has an easy ...
Tags: Treatment of Diabetes, Insulin Pen
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Levemir (insulin detemir [rDNA origin] injection) for a pregnancy Category B classification. The approval indicates that Levemir, when used in pregnant women with ...
Tags: FDA approval, lable update, Levemir, clinical study
The FDA has approved Novo Nordisk Levemir (insulin detemir [rDNA origin] injection) for use in children with type 1 diabetes. The basal insulin analog is approved for type 1 diabetes patients from age two through adulthood and adult ...
Tags: FDA, Levemir, treatment for type 1 diabetes